All
First-Line Opdivo-Novel Therapy Combo More Than Doubles Survival in Advanced Skin Cancer
May 20th 2021The use of Opdivo combined with the novel therapy relatlimab resulted in a significant improvement of progression-free survival compared to treatment with Opdivo, alone, in patients with previously untreated, unresectable or metastatic melanoma.
FDA Approves Opdivo for Adjuvant Treatment of Esophageal and Gastroesophageal Junction Cancer
May 20th 2021Opdivo was approved by the FDA for use if disease persisted after neoadjuvant chemoradiotherapy in these patients, which is “exciting news,” as patients would typically undergo surveillance when this occurred.
The Double Whammy of Cancer and COVID-19 on Mental Health
May 20th 2021In this episode of the “CURE® Talks Cancer” podcast, Dr. William Breitbart, chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center, discusses the impact of the COVID-19 pandemic on mental health within the cancer community and what people can do to manage this extra strain.
Helping a Loved One Cope with Advanced Cancer
May 19th 2021When a patient’s cancer care team determines treatment is no longer working, it’s time to make some difficult decisions regarding long-term care, writes one breast cancer survivor. Here, she shares advice on how family members can offer their love and support.
Doctor Recommends COVID-19 Vaccine for Adolescent Patients with Cancer
May 18th 2021Recent CDC recommendations that children ages 12 to 15 are eligible to receive the Pfizer COVID-19 vaccine can include patients with cancer, except under certain extreme circumstances, says an expert from St. Jude Children’s Research Hospital.